GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ADAG
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Adagene Inc. stock price down 0% on Friday
(Updated on Apr 19, 2024)

Sell candidate since Apr 11, 2024 Loss -6.38% PDF

No changes to the price of Adagene Inc. stock on the last trading day (Friday, 19th Apr 2024). During the last trading day the stock fluctuated 4.99% from a day low at $2.51 to a day high of $2.64. The price has fallen in 5 of the last 10 days and is down by -7.37% for this period.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.77% during the next 3 months and, with a 90% probability hold a price between $1.64 and $2.32 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ADAG Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, March 26, 2024, and so far it has risen 5.18%. Further rise is indicated until a new top pivot has been found. Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Adagene Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.65 and $2.83. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Adagene Inc. stock

Adagene Inc. finds support from accumulated volume at $2.61 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.126 between high and low, or 4.99%. For the last week, the stock has had daily average volatility of 5.38%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ADAG) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Adagene Inc. to open at $2.60, and during the day (based on 14 day Average True Range), to move between $2.39 and $2.89, which gives a possible trading interval of +/-$0.245 (+/-9.29%) up or down from last closing price. If Adagene Inc. takes out the full calculated possible swing range there will be an estimated 18.59% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.61 (1.14%) than the resistance at $3.00 (13.64%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Adagene Inc. stock A Buy?

Adagene Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.992 Sell Candidate Unchanged

Predicted Opening Price for Adagene Inc. of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$2.60 ( 1.58%) $2.64

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ADAG

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.72 3.17 %
R2 2.68 1.35 %
R1 2.65 0.231 %
Current price: 2.64
Support S1 2.55 -3.40 %
S2 2.52 -4.52 %
S3 2.47 -6.34 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.25 22.92 %
R2 3.04 15.15 %
R1 3.00 13.64 %
Current price 2.64
Support S1 2.61 -1.14%
S2 2.53 -4.17%
S3 2.51 -4.92%

FAQ

What is the symbol for Adagene Inc. Stock and on which exchange is it traded?
The symbol for Adagene Inc. is ADAG and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Adagene Inc. Stock?
Adagene Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Adagene Inc. Stock?
Adagene Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Adagene Inc. Stock.

What's the current price of Adagene Inc. Stock?
As of the end of day on the 2024-04-19, the price of an Adagene Inc. (ADAG) share was $2.64.

What is the 52-week high and low for Adagene Inc. Stock?
The 52-week high for Adagene Inc. Stock is $4.38 and the 52-week low is $1.10.

What is the market capitalization of Adagene Inc. Stock?
As of the 2024-04-19, the market capitalization of Adagene Inc. is 116.468M.

When is the next earnings date for Adagene Inc.?
The upcoming earnings date for Adagene Inc. is Aug 29, 2024.
Click to get the best stock tips daily for free!

About Adagene Inc.

Adagene. Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid tumors and non-Hodgkin's lymphoma; ADG126, a fully-human anti-CTLA-4 mAb that is in Phase 1 clinical tr... ADAG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT